Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition for anticancer adjuvant comprising RIP3 expression promoter as active ingredient, method for screening anticancer adjuvant which promotes RIP3 expression and enhances sensitivity of anticancer agent, and method for monitoring sensitivity of anticancer agent

Composition for anticancer adjuvant comprising RIP3 expression promoter as active ingredient, method for screening anticancer adjuvant which promotes RIP3 expression and enhances sensitivity of anticancer agent, and method for monitoring sensitivity of anticancer agent

US Patent 10921325 · Granted Feb 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Security analysis system and method based on negative testing for protocol imple2025
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen rec2025
Composition for treating or preventing colitis by NAMPT metabolic regulation2025
Early detection marker for degenerative osteoarthritis with TRIM24-RIP3 axis2024
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen rec2024
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen rec2023
Method of diagnosing and treating skin necroptosis disease comprising RIP3-MLKL 2020
Anticancer adjuvant composition containing RIP3 expression promoter as active in2019
Anticancer adjuvant composition containing RIP3 expression promoter as active in2019
Method of preventing or treating skin necroptosis disease comprising RIP3-MLKL p2018
Gut flora-derived extracellular vesicles, and method for searching for a disease2016
Gut flora-derived extracellular vesicles, and method for searching for a disease2015